238 related articles for article (PubMed ID: 31575007)
1. Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma.
Lee JH; Rangappa S; Mohan CD; ; Sethi G; Lin ZX; Rangappa KS; Ahn KS
Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31575007
[TBL] [Abstract][Full Text] [Related]
2. Effects of ethyl acetate extract of peony (Paeonia suffruticosa) seed coat on the proliferation and apoptosis of oral squamous carcinoma cells through miR-424-3p/STAT3/Survivin pathway.
Ren S; Qing S
Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):52-58. PubMed ID: 33040785
[TBL] [Abstract][Full Text] [Related]
3. (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells.
Lin HY; Hou SC; Chen SC; Kao MC; Yu CC; Funayama S; Ho CT; Way TD
J Agric Food Chem; 2012 Mar; 60(10):2480-9. PubMed ID: 22313388
[TBL] [Abstract][Full Text] [Related]
4. miR-204 inhibits angiogenesis and promotes sensitivity to cetuximab in head and neck squamous cell carcinoma cells by blocking JAK2-STAT3 signaling.
Wu Q; Zhao Y; Wang P
Biomed Pharmacother; 2018 Mar; 99():278-285. PubMed ID: 29353201
[TBL] [Abstract][Full Text] [Related]
5. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane).
Chakravarti N; Myers JN; Aggarwal BB
Int J Cancer; 2006 Sep; 119(6):1268-75. PubMed ID: 16642480
[TBL] [Abstract][Full Text] [Related]
6. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
[TBL] [Abstract][Full Text] [Related]
7. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
[TBL] [Abstract][Full Text] [Related]
8. The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway.
Xu Q; Ma H; Chang H; Feng Z; Zhang C; Yang X
Cell Death Dis; 2020 May; 11(5):405. PubMed ID: 32471980
[TBL] [Abstract][Full Text] [Related]
9. C188-9, a small-molecule STAT3 inhibitor, exerts an antitumor effect on head and neck squamous cell carcinoma.
Di JX; Zhang HY
Anticancer Drugs; 2019 Sep; 30(8):846-853. PubMed ID: 30870229
[TBL] [Abstract][Full Text] [Related]
10. Suppression of the Growth and Invasion of Human Head and Neck Squamous Cell Carcinomas via Regulating STAT3 Signaling and the miR-21/β-catenin Axis with HJC0152.
Wang Y; Wang S; Wu Y; Ren Y; Li Z; Yao X; Zhang C; Ye N; Jing C; Dong J; Zhang K; Sun S; Zhao M; Guo W; Qu X; Qiao Y; Chen H; Kong L; Jin R; Wang X; Zhang L; Zhou J; Shen Q; Zhou X
Mol Cancer Ther; 2017 Apr; 16(4):578-590. PubMed ID: 28138036
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells.
Baek SH; Ko JH; Lee H; Jung J; Kong M; Lee JW; Lee J; Chinnathambi A; Zayed ME; Alharbi SA; Lee SG; Shim BS; Sethi G; Kim SH; Yang WM; Um JY; Ahn KS
Phytomedicine; 2016 May; 23(5):566-77. PubMed ID: 27064016
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
Yang Z; Liao J; Carter-Cooper BA; Lapidus RG; Cullen KJ; Dan H
BMC Cancer; 2019 May; 19(1):485. PubMed ID: 31118072
[TBL] [Abstract][Full Text] [Related]
13. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.
Sen M; Pollock NI; Black J; DeGrave KA; Wheeler S; Freilino ML; Joyce S; Lui VW; Zeng Y; Chiosea SI; Grandis JR
Neoplasia; 2015 Mar; 17(3):256-64. PubMed ID: 25810010
[TBL] [Abstract][Full Text] [Related]
14. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
15. Carnosic acid inhibits STAT3 signaling and induces apoptosis through generation of ROS in human colon cancer HCT116 cells.
Kim DH; Park KW; Chae IG; Kundu J; Kim EH; Kundu JK; Chun KS
Mol Carcinog; 2016 Jun; 55(6):1096-110. PubMed ID: 26152521
[TBL] [Abstract][Full Text] [Related]
16. Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling pathway.
Xiang Y; Ye W; Huang C; Lou B; Zhang J; Yu D; Huang X; Chen B; Zhou M
Biochem Biophys Res Commun; 2017 Jun; 487(4):820-826. PubMed ID: 28455228
[TBL] [Abstract][Full Text] [Related]
17. Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.
Squarize CH; Castilho RM; Sriuranpong V; Pinto DS; Gutkind JS
Neoplasia; 2006 Sep; 8(9):733-46. PubMed ID: 16984731
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma.
Zhuang Z; Yu P; Xie N; Wu Y; Liu H; Zhang M; Tao Y; Wang W; Yin H; Zou B; Hou J; Liu X; Li J; Huang H; Wang C
Theranostics; 2020; 10(3):1433-1453. PubMed ID: 31938073
[TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling.
Jia L; Song Q; Zhou C; Li X; Pi L; Ma X; Li H; Lu X; Shen Y
PLoS One; 2016; 11(1):e0147157. PubMed ID: 26784960
[TBL] [Abstract][Full Text] [Related]
20. STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner.
Sun S; Wu Y; Guo W; Yu F; Kong L; Ren Y; Wang Y; Yao X; Jing C; Zhang C; Liu M; Zhang Y; Zhao M; Li Z; Wu C; Qiao Y; Yang J; Wang X; Zhang L; Li M; Zhou X
Clin Cancer Res; 2018 Jun; 24(11):2665-2677. PubMed ID: 29540490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
